RecruitingNot ApplicableNCT06491537

Time-restricted Eating for Postpartum Weight Loss

Use of Early Time-restricted Eating to Promote Weight Loss and Improve Cardiometabolic Health in Postpartum Women


Sponsor

University of Alabama at Birmingham

Enrollment

60 participants

Start Date

May 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • years of age or older
  • Experienced a healthy singleton pregnancy
  • -16 weeks postpartum at enrollment
  • Body mass index ≥25 at enrollment
  • Willing to consent

Exclusion Criteria9

  • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
  • Current treatment for severe psychiatric disorder (such as schizophrenia)
  • Self-reported diagnosis of anorexia or bulimia
  • Current use of medication expected to significantly impact body weight
  • Current substance abuse
  • Participation in another dietary and/or weight management intervention postpartum
  • Performing overnight shiftwork >1x/week
  • Regularly fasting ≥14 hr/day or completing twelve or more 24-hr fasts within the past year
  • Unable to understand and communicate in English

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEarly Time-Restricted Eating (eTRE)

12 weeks of eTRE intervention. Study staff will provide 7 support sessions with brief behavioral support, including evidence based strategies of problem-solving, action planning, and motivational interviewing.

BEHAVIORALControl

The control group will be instructed to maintain their average eating window for the 12-week period. Study staff will contact participants 7 times to encourage maintenance.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06491537


Related Trials